Cargando…

Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study

OBJECTIVE: We describe baseline characteristics, time to treatment initiation and interim patient outcomes at a decentralized, outpatient treatment site for rifampicin-resistant TB (RR-TB). METHODS: Prospective observational cohort study of RR-TB patients from March 2013 until December 2014. Study s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berhanu, Rebecca, Schnippel, Kathryn, Mohr, Erika, Hirasen, Kamban, Evans, Denise, Rosen, Sydney, Sanne, Ian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094796/ https://www.ncbi.nlm.nih.gov/pubmed/27812140 http://dx.doi.org/10.1371/journal.pone.0164974

Ejemplares similares

Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa
por: van Rensburg, Craig, et al.
Publicado: (2019)

High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa
por: Hirasen, Kamban, et al.
Publicado: (2018)

Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2018)

Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2017)

Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2018)

The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa
por: Sineke, Tembeka, et al.
Publicado: (2019)

Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2018)

The right combination – treatment outcomes among HIV-positive patients initiating first-line fixed-dose antiretroviral therapy in a public sector HIV clinic in Johannesburg, South Africa
por: Hirasen, Kamban, et al.
Publicado: (2017)

The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa
por: Long, Lawrence C., et al.
Publicado: (2016)

Using a Self-Administered Electronic Adherence Questionnaire to Identify Poor Adherence Amongst Adolescents and Young Adults on First-Line Antiretroviral Therapy in Johannesburg, South Africa
por: Hirasen, Kamban, et al.
Publicado: (2020)

Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa
por: d'Elia, Alexander, et al.
Publicado: (2015)

The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2014)

Pneumonic Plague in Johannesburg, South Africa, 1904
por: Evans, Charles M., et al.
Publicado: (2018)

Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
por: Schnippel, Kathryn, et al.
Publicado: (2012)

Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study
por: Schnippel, Kathryn, et al.
Publicado: (2016)

Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa
por: Larson, Bruce A, et al.
Publicado: (2010)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa
por: Cox, Helen S., et al.
Publicado: (2015)

Delays, interruptions, and losses from prevention of mother-to-child transmission of HIV services during antenatal care in Johannesburg, South Africa: a cohort analysis
por: Schnippel, Kathryn, et al.
Publicado: (2015)

Same-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not Enough
por: Larson, Bruce A., et al.
Publicado: (2013)

The Impact of Choice of NNRTI on Short-Term Treatment Outcomes among HIV-Infected Patients Prescribed Tenofovir and Lamivudine in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2013)

HIV Treatment Outcomes Among Patients Initiated on Antiretroviral Therapy Pre and Post-Universal Test and Treat Guidelines in South Africa
por: Hirasen, Kamban, et al.
Publicado: (2020)

Uptake of same-day initiation of HIV treatment in Malawi, South Africa, and Zambia as reported in routinely collected data: the SPRINT retrospective cohort study
por: Huber, Amy, et al.
Publicado: (2023)

Environmental Silica Dust Exposure and Pulmonary Tuberculosis in Johannesburg, South Africa
por: Kootbodien, Tahira, et al.
Publicado: (2019)

Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa
por: Mohr, Erika, et al.
Publicado: (2018)

Treatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South Africa
por: Moyo, Faith, et al.
Publicado: (2016)

Treatment outcomes of over 1000 patients on second‐line, protease inhibitor‐based antiretroviral therapy from four public‐sector HIV treatment facilities across Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2016)

Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa
por: Onoya, Dorina, et al.
Publicado: (2017)

Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa
por: Onoya, Dorina, et al.
Publicado: (2018)

Perceived efficacy of HIV treatment-as-prevention among university students in Johannesburg, South Africa
por: Bor, Jacob, et al.
Publicado: (2021)

High Tuberculosis and HIV Coinfection Rate, Johannesburg
por: John, Melanie-Anne, et al.
Publicado: (2007)

Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa
por: Salaam-Dreyer, Zubeida, et al.
Publicado: (2021)

How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere Pima™ Analyzer in South Africa
por: Larson, Bruce, et al.
Publicado: (2012)

Prevalence of latent tuberculosis infection and predictive factors in an urban informal settlement in Johannesburg, South Africa: a cross-sectional study
por: Ncayiyana, Jabulani R., et al.
Publicado: (2016)

Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa
por: Rosen, Sydney, et al.
Publicado: (2010)

Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa
por: Leavitt, Sarah V., et al.
Publicado: (2021)

Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South Africa
por: Mohr-Holland, Erika, et al.
Publicado: (2020)

HIV-Associated Disseminated Emmonsiosis, Johannesburg, South Africa
por: van Hougenhouck-Tulleken, Wesley G., et al.
Publicado: (2014)

Sarcoidosis in Johannesburg, South Africa: A retrospective study
por: Morar, R, et al.
Publicado: (2022)

Increases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South Africa
por: Brennan, Alana T, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gi3ne8ubbq1gf7t5o2hbhcfeef